Biocompatible Injectable Hydrogel with Potent Wound Healing and Antibacterial Properties
Overview
Affiliations
Two component injectable hydrogels that cross-link in situ have been used as noninvasive wound-filling devices, i.e., sealants. These materials carry a variety of functions at the wound sites, such as sealing leaks, ceasing unwanted bleeding, binding tissues together, and assisting in wound healing processes. However, commonly used sealants typically lack antibacterial properties. Since bacterial infection at the wound site is very common, bioadhesive materials with intrinsic antibacterial properties are urgently required. Herein, we report a biocompatible injectable hydrogel with inherent bioadhesive, antibacterial, and hemostatic capabilities suitable for wound sealing applications. The hydrogels were developed in situ from an antibacterial polymer, N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), and a bioadhesive polymer, polydextran aldehyde. The gels were shown to be active against both Gram-positive and Gram-negative bacteria, including drug-resistant ones such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and β-lactam-resistant Klebsiela pneumoniae. Mechanistic studies revealed that the gels killed bacteria upon contact by disrupting the membrane integrity of the pathogen. Importantly, the gels were shown to be efficacious in preventing sepsis in a cecum ligation and puncture (CLP) model in mice. While only 12.5% of animals survived in the case of mice with punctured cecam but with no gel on the punctured area (control), 62.5% mice survived when the adhesive gel was applied to the punctured area. Furthermore, the gels were also shown to be effective in facilitating wound healing in rats and ceasing bleeding from a damaged liver in mice. Notably, the gel showed negligible toxicity toward human red blood cells (only 2-3% hemolysis) and no inflammation to the surrounding tissue upon subcutaneous implantation in mice, thus proving it as a safe and effective antibacterial sealant.
Datta D, Colaco V, Bandi S, Dhas N, Janardhanam L, Singh S ACS Biomater Sci Eng. 2025; 11(3):1338-1372.
PMID: 39999055 PMC: 11897956. DOI: 10.1021/acsbiomaterials.4c02264.
Current Insight of Peptide-Based Hydrogels for Chronic Wound Healing Applications: A Concise Review.
Nizam A, Masri S, Fadilah N, Maarof M, Fauzi M Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861121 PMC: 11768948. DOI: 10.3390/ph18010058.
Wu Q, Ghosal K, Kanaan N, Roy S, Rashed N, Majumder R Bioact Mater. 2024; 44:116-130.
PMID: 39484021 PMC: 11525126. DOI: 10.1016/j.bioactmat.2024.10.003.
Progress in injectable hydrogels for the treatment of incompressible bleeding: an update.
Wang X, Yang X, Sun Z, Guo X, Teng Y, Hou S Front Bioeng Biotechnol. 2024; 11:1335211.
PMID: 38264581 PMC: 10803650. DOI: 10.3389/fbioe.2023.1335211.
Smart and versatile biomaterials for cutaneous wound healing.
Li M, Xia W, Khoong Y, Huang L, Huang X, Liang H Biomater Res. 2023; 27(1):87.
PMID: 37717028 PMC: 10504797. DOI: 10.1186/s40824-023-00426-2.